keyword
https://read.qxmd.com/read/38623708/understanding-the-treatment-paradigm-and-the-sequencing-of-antiglaucoma-fixed-dose-combinations-in-a-tertiary-center-in-south-india
#1
JOURNAL ARTICLE
Ronnie George, Praggya Mishra, Balekudaru Shantha, Lingam Vijaya, Nitin Maksane, Neha Gurha
PURPOSE: To analyze the medical management of primary open-angle glaucoma (POAG) and ocular hypertension (OHT) and the placement of fixed-drug combination drugs (FDC) in the treatment paradigm at a tertiary eye care center in South India. METHODS: Retrospective study (January 2011-December 2015) of newly diagnosed POAG and OHT patients (≥18 years) with ≥5 years follow-up. Primary outcome included percentage use of different antiglaucoma drugs (at initiation) and FDCs at the first, second, and third progression (sequencing)...
April 16, 2024: Indian Journal of Ophthalmology
https://read.qxmd.com/read/38608200/colorimetric-concurrent-determination-of-ultra-trace-amounts-of-pilocarpine-and-timolol-as-anti-glaucoma-drugs-in-binary-mixtures-using-a-multivariate-calibration-approach-based-on-the-aggregation-of-gold-nanoparticles
#2
JOURNAL ARTICLE
Asma Zanjani, Mahmoud Reza Sohrabi, Hassan Kabiri Fard
BACKGROUND: To study the ultra-trace simultaneous determination of drugs, the colorimetric method in combination with chemometrics can be used. OBJECTIVE: In this study, a simple, rapid, and sensitive UV-Vis spectrophotometric method using gold nanoparticles (AuNPs) was introduced for the simultaneous determination of ultra-trace amounts of Pilocarpine (PIL) and Timolol (TIM) in binary mixtures and biological sample. METHODS: AuNPs interacted with components and the aggregation mode of NPs occurred and finally, the color change of the solution (red to gray) was observed with the naked eye without the most modern and expensive instruments...
April 12, 2024: Journal of AOAC International
https://read.qxmd.com/read/38598266/a-comparative-study-on-efficacy-of-intraocular-pressure-lowering-of-two-fixed-dose-antiglaucoma-drug-combination-brinzolamide-brimonidine-versus-latanoprost-timolol-in-primary-open-angle-glaucoma-and-ocular-hypertension
#3
JOURNAL ARTICLE
Avinash Mishra, Mohini Agrawal, Anchal Tripathi, Atul Bhirud, Lt Col Rajnish Kumar, Brig Baranwal Vinod K
Purpose: To compare the efficacy of Brinzolamide-Brimonidine (BB) (1%+0.2%) with the gold standard Latanoprost-Timolol (LT) (0.005%+0.5%) in treating primary open-angle glaucoma (POAG) and ocular hypertension (OHT). Methods: A 1-year prospective study, spanning from May 2022 to May 2023, conducted at a tertiary eye-care hospital. Participants, aged 40-60, with a baseline intraocular pressure (IOP) >21 mm Hg, requiring a >30% reduction, were enrolled. Group A ( n  = 100) received BB, and Group B ( n  = 100) received LT...
April 10, 2024: Journal of Ocular Pharmacology and Therapeutics
https://read.qxmd.com/read/38585162/glaucoma-drug-prescription-pattern-in-north-india-public-vs-private-sector-hospitals
#4
JOURNAL ARTICLE
Shibal Bhartiya, Parul Ichhpujani, Uday Pratap Singh Parmar, Surbhi Kapoor, Sonali Kaundal, Suresh Kumar
BACKGROUND: Glaucoma is an optic neuropathy associated with characteristic structural damage to the optic nerve and associated visual dysfunction that may be caused by various pathological processes. A number of pharmacological agents are used to reduce the intraocular pressure (IOP), involving the usage of two or three medications concurrently. Literature is sparse regarding prescription patterns of antiglaucoma drugs, especially regarding variability in public sector vs private sector hospitals...
2024: Journal of Current Glaucoma Practice
https://read.qxmd.com/read/38578377/manufacturing-and-characterisation-of-3d-printed-sustained-release-timolol-implants-for-glaucoma-treatment
#5
JOURNAL ARTICLE
Fathima Paleel, Mengqi Qin, Aristides D Tagalakis, Cynthia Yu-Wai-Man, Dimitrios A Lamprou
Timolol maleate (TML) is a beta-blocker drug that is commonly used to lower the intraocular pressure in glaucoma. This study focused on using a 3D printing (3DP) method for the manufacturing of an ocular, implantable, sustained-release drug delivery system (DDS). Polycaprolactone (PCL), and PCL with 5 or 10% TML implants were manufactured using a one-step 3DP process. Their physicochemical characteristics were analysed using light microscopy, scanning electronic microscopy (SEM), differential scanning calorimetry (DSC) / thermal gravimetric analysis (TGA), and Fourier-transform infrared spectroscopy (FTIR)...
April 5, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38573903/timolol-in-the-treatment-of-hard-to-heal-wounds-a-comprehensive-review
#6
REVIEW
David Cornwell, Zachary Goldstein, Bopha Chrea, Robert McLafferty
OBJECTIVE: The aims of this study were to ascertain the effectiveness and safety of the off-label use of topical timolol as an adjunct treatment for hard-to-heal (chronic) wounds. Furthermore, to review and analyse the existing literature regarding the use of topical timolol on wounds of varying aetiologies. METHOD: A systematic review of literature in the English language published between May 1961-May 2021 on the application of topical timolol for hard-to-heal wounds in adults was performed...
April 2, 2024: Journal of Wound Care
https://read.qxmd.com/read/38572057/topical-timolol-as-a-therapeutic-modality-in-severe-disfiguring-infantile-haemangioma
#7
JOURNAL ARTICLE
Mohita Mahajan, Bharat Bhushan Mahajan
No abstract text is available yet for this article.
2024: Indian Journal of Dermatology
https://read.qxmd.com/read/38562246/successful-management-of-bilateral-uncontrolled-advanced-primary-open-angle-glaucoma-in-a-pregnant-woman-during-the-restrictive-covid-19-lockdown
#8
JOURNAL ARTICLE
Asem A Alqudah, Abdelwahab Aleshawi
COVID-19 is a viral illness that can cause severe respiratory symptoms. COVID-19 has caused a worldwide pandemic that necessitated many countries to perform a national lockdown. In Jordan, a lockdown was imposed by the government. During the lockdown, the hospitals were only dealing with outpatient emergency cases, urgent referrals from primary or secondary health institutions, and inpatients whose medical conditions required keeping them admitted. Elective clinics and surgeries were canceled. At the King Abdullah University Hospital (KAUH), which is the only tertiary center in northern Jordan, we dealt with an unusual case of uncontrolled and advanced primary open angle glaucoma in a 38-year-old pregnant female patient...
2024: Clinical Optometry
https://read.qxmd.com/read/38542305/steroid-induced-ocular-hypertension-in-mice-is-differentially-reduced-by-selective-ep2-ep3-ep4-and-ip-prostanoid-receptor-agonists
#9
JOURNAL ARTICLE
Najam A Sharif, J Cameron Millar, Gulab Zode, Takashi Ota
We tested five chemically and metabolically stable prostaglandin (PG) receptor agonists in a mouse model of dexamethasone-induced ocular hypertension (OHT). Whilst all compounds significantly ( p < 0.05, ANOVA) lowered intraocular pressure (IOP) after twice-daily bilateral topical ocular dosing (5 µg/dose) over three weeks, the time course and magnitude of the responses varied. The onset of action of NS-304 (IP-PG receptor agonist) and rivenprost (EP4-PG receptor agonist) was slower than that of misoprostol (mixed EP2/EP3/EP4-PG receptor agonist), PF-04217329 (EP2-PG receptor agonist), and butaprost (EP2-PG receptor agonist)...
March 15, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38516792/a-new-case-of-contact-allergic-reaction-caused-by-topical-timolol-and-literature-review
#10
Inaya Mahmoud, Malena Gergovska, Jana Kazandjieva
No abstract text is available yet for this article.
March 22, 2024: Contact Dermatitis
https://read.qxmd.com/read/38492865/an-evaluation-of-the-efficacy-and-safety-of-timolol-maleate-0-5-microdrops-administered-with-the-nanodropper%C3%A2
#11
JOURNAL ARTICLE
Jennifer S Steger, Indira Durai, Annamalai Odayappan, Ramalakshmi Raman, Talla Sruthi, Allisa J Song, George Puthuran, Rengaraj Venkatesh, Elizabeth Colantuoni, Alan L Robin
OBJECTIVE OR PURPOSE: Examine if 12.5 μL timolol maleate 0.5% microdrops dispensed with the Nanodropper® Adaptor provide non-inferior intraocular pressure (IOP) reduction compared to conventional, 28 μL drops in open-angle glaucoma (OAG) and ocular hypertension (OHT) patients. DESIGN: Prospective, non-inferiority, parallel, multicenter, single-masked, active-controlled, randomized trial. SUBJECTS, PARTICIPANTS, AND/OR CONTROLS: Treatment-naïve subjects that were recently diagnosed with OAG/OHT at the Aravind Eye Care System...
March 14, 2024: Ophthalmology
https://read.qxmd.com/read/38465363/outcomes-of-eyes-lost-to-follow-up-after-treatment-with-intraocular-or-periocular-steroid-injections
#12
JOURNAL ARTICLE
Raziyeh Mahmoudzadeh, Mirataollah Salabati, Rachel Israilevich, John W Hinkle, Anthony Obeid, M Ali Khan, Jason Hsu, Varun Chaudhary, Sunir J Garg
Purpose: To evaluate the visual, intraocular pressure (IOP), and anatomic outcomes of eyes with loss to follow-up (LTFU) after intravitreal or periocular steroid injections. Methods: Patients receiving intraocular or periocular steroid injections and with LTFU for at least 180 days were included in this retrospective cohort study. Charts were reviewed for the visual acuity (VA), IOP, and central foveal thickness at the visit before LTFU, the first return visit, and 3, 6, and 12 months after return. Results: Fifty-three eyes of 47 patients were identified...
2024: Journal of Vitreoretinal Diseases
https://read.qxmd.com/read/38423796/the-role-of-%C3%AE-adrenergic-receptors-in-the-regulation-of-cardiac-tolerance-to-ischemia-reperfusion-why-do-%C3%AE-adrenergic-receptor-agonists-and-antagonists-protect-the-heart
#13
REVIEW
Leonid N Maslov, Natalia V Naryzhnaya, Nikita S Voronkov, Boris K Kurbatov, Ivan A Derkachev, Vyacheslav V Ryabov, Evgeny V Vyshlov, Viktor V Kolpakov, Eugenia A Tomilova, Ekaterina V Sapozhenkova, Nirmal Singh, Feng Fu, Jianming Pei
BACKGROUND: Catecholamines and β-adrenergic receptors (β-ARs) play an important role in the regulation of cardiac tolerance to the impact of ischemia and reperfusion. This systematic review analyzed the molecular mechanisms of the cardioprotective activity of β-AR ligands. METHODS: We performed an electronic search of topical articles using PubMed databases from 1966 to 2023. We cited original in vitro and in vivo studies and review articles that documented the cardioprotective properties of β-AR agonists and antagonists...
February 29, 2024: Fundamental & Clinical Pharmacology
https://read.qxmd.com/read/38423216/phase-3-randomized-clinical-trial-of-the-safety-and-efficacy-of-travoprost-intraocular-implant-in-patients-with-open-angle-glaucoma-or-ocular-hypertension
#14
JOURNAL ARTICLE
Steven R Sarkisian, Robert E Ang, Andy M Lee, John P Berdahl, Sebastian B Heersink, James H Burden, Long V Doan, Kerry G Stephens, Angela C Kothe, Dale W Usner, L Jay Katz, Tomas Navratil
PURPOSE: Evaluate the safety and intraocular pressure (IOP)-lowering efficacy of two models of the travoprost intraocular implant (fast-eluting [FE-implant] and slow eluting [SE-implant]) from one of two pivotal trials (GC-010). DESIGN: Phase 3, multicenter, randomized, double-masked, sham-controlled, non-inferiority trial. PARTICIPANTS: Subjects with open-angle glaucoma or ocular hypertension, using 0 to 3 IOP-lowering medications at screening and having an unmedicated baseline mean diurnal IOP (average of 8AM, 10AM and 4PM timepoints) of ≥ 21 mmHg, and an unmedicated baseline IOP of ≤ 36 mmHg at each timepoint in the study eye...
February 27, 2024: Ophthalmology
https://read.qxmd.com/read/38407770/chitosan-nanoparticles-laden-contact-lenses-for-enzyme-triggered-controlled-delivery-of-timolol-maleate-a-promising-strategy-for-managing-glaucoma
#15
JOURNAL ARTICLE
Furqan A Maulvi, Ashmi R Patel, Kiran H Shetty, Ditixa T Desai, Dinesh O Shah, Mark D P Willcox
To improve drug bioavailability, eye drops can be replaced by drug-eluting contact lenses. However, issues of drug leaching from lenses during manufacture and storage, and sterilization, currently limit their commercial application. To address the issues, stimuli-(lysozyme)-sensitive chitosan nanoparticles were developed to provide controlled ocular drug delivery. Nanoparticles were prepared by ionic gelation and characterized by TEM, X-ray diffraction, DSC, and FTIR. In the flux study, conventional-soaked contact lenses (SM-TM-CL) showed high-burst release, while with direct drug-only laden contact lenses (DL-TM-CL) the drug was lost during extraction and sterilization, as well as having poor swelling and optical properties...
February 26, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38404426/nasally-delivered-0-5-timolol-beta-blocker-successfully-treats-acute-migraines-in-a-referral-headache-clinic-a-case-series
#16
JOURNAL ARTICLE
Steven C Kosa, John C Hagan
This is the first reported case series of nasally delivered beta blocker (timolol 0.5%) for the treatment of acute migraine. In a retrospective chart review, 16 patients were found who had received intranasal timolol for sub-optimally treated acute migraines. Of these, 10 (62.5%) reported to their provider that the medication was helpful. Encouragingly, the treatment was beneficial even for patients previously refractory to other medications. Intranasal timolol was well tolerated, with only one patient reporting mild nasal congestion and no other side effects reported...
2024: Missouri Medicine
https://read.qxmd.com/read/38404425/first-world-literature-report-attention-pharma-headache-researchers-nasal-spray-timolol-may-be-the-next-great-thing-for-acute-migraine
#17
EDITORIAL
https://read.qxmd.com/read/38395819/rare-complication-skin-atrophy-after-systemic-conservative-therapy-of-infantile-hemangioma
#18
JOURNAL ARTICLE
Konstantine Chakhunashvili, Eka Kvirkvelia, Natia Todua, Davit G Chakhunashvili
BACKGROUND: Hemangiomas, also called infantile hemangiomas (IH) or hemangiomas of infancy are the most frequently seen benign vascular tumors of infancy. Different types of hemangiomas are described in the literature. The current approach is to assess the risk and, if needed, first line treatment is to initiate systemic propranolol. CASE PRESENTATION: A 3-month-old Caucasian female patient was brought as an outpatient. The main complaint was an infantile hemangioma in the facial area, which as per the parents' story appeared within a week of birth like a small reddish line and it rapidly grew...
February 23, 2024: BMC Pediatrics
https://read.qxmd.com/read/38395329/omidenepag-isopropyl-versus-timolol-in-patients-with-glaucoma-or-ocular-hypertension-two-randomized-phase-3-trials-spectrum-4-and-3
#19
JOURNAL ARTICLE
Jason Bacharach, Jacob W Brubaker, David G Evans, Fenghe Lu, Noriko Odani-Kawabata, Takaharu Yamabe, David L Wirta
PURPOSE: The SPECTRUM 4 and 3 studies assessed the intraocular pressure (IOP)-lowering efficacy and safety of omidenepag isopropyl (OMDI) 0.002% vs timolol 0.5% in patients with glaucoma or ocular hypertension (OHT). DESIGN: Phase 3, randomized, controlled, double-masked, noninferiority studies. METHODS: Multicenter studies in the US. Inclusion criteria for adults ≥ 18 years (SPECTRUM 4 [N = 409] and 3 [N = 413]) were open-angle glaucoma or OHT, and IOP ≥ 22 mm Hg and ≤ 34 mm Hg; and for pediatric patients < 18 years (N = 13, SPECTRUM 3) were pediatric glaucoma or OHT...
February 21, 2024: American Journal of Ophthalmology
https://read.qxmd.com/read/38376643/the-effect-of-combination-therapy-with-intravitreal-bevacizumab-and-topical-timolol-dorzolamide-eye-drops-on-diabetic-macular-edema-a-double-blind-randomized-controlled-trial
#20
RANDOMIZED CONTROLLED TRIAL
Sahba Fekri, Ali Rabiei, Sadid Hooshmandi, Hosein Nouri, Seyed-Hossein Abtahi
BACKGROUND: The mainstay of treatment in diabetic macular edema (DME) is intravitreal administration of anti-vascular endothelial growth factors (anti-VEGFs). Aqueous depressants may enhance the effects of anti-VEGF agents by prolonging their clearance via aqueous outflow. PURPOSE: To compare the anatomical and functional outcomes of treatment with intravitreal bevacizumab (IVB) and topical timolol-dorzolamide versus IVB alone. METHOD: In this randomized placebo-controlled clinical trial, patients with center-involving DME (ci-DME) and best corrected visual acuity (BCVA) of 20/30 or less were enrolled and randomly allocated to two treatment arms...
February 20, 2024: International Ophthalmology
keyword
keyword
26347
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.